- Home
- AZTA vs RDY Comparison
AZTA vs RDY Comparison
Compare AZTA & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- RDY
- Stock Information
- Founded
- AZTA 1978
- RDY 1984
- Country
- AZTA United States
- RDY India
- Employees
- AZTA N/A
- RDY N/A
- Industry
- AZTA Industrial Machinery/Components
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- AZTA Technology
- RDY Health Care
- Exchange
- AZTA Nasdaq
- RDY Nasdaq
- Market Cap
- AZTA 1.8B
- RDY 2.1B
- IPO Year
- AZTA 1995
- RDY N/A
- Fundamental
- Price
- AZTA $29.64
- RDY $15.23
- Analyst Decision
- AZTA Buy
- RDY Strong Buy
- Analyst Count
- AZTA 3
- RDY 2
- Target Price
- AZTA $50.67
- RDY $16.95
- AVG Volume (30 Days)
- AZTA 703.4K
- RDY 1.7M
- Earning Date
- AZTA 08-05-2025
- RDY 07-28-2025
- Dividend Yield
- AZTA N/A
- RDY 0.63%
- EPS Growth
- AZTA N/A
- RDY 1.47
- EPS
- AZTA N/A
- RDY 0.79
- Revenue
- AZTA $669,171,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- AZTA N/A
- RDY $10.24
- Revenue Next Year
- AZTA $4.89
- RDY N/A
- P/E Ratio
- AZTA N/A
- RDY $19.24
- Revenue Growth
- AZTA 8.56
- RDY 16.61
- 52 Week Low
- AZTA $23.91
- RDY $12.26
- 52 Week High
- AZTA $63.58
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- AZTA 54.22
- RDY 55.04
- Support Level
- AZTA $29.16
- RDY $15.16
- Resistance Level
- AZTA $30.86
- RDY $16.17
- Average True Range (ATR)
- AZTA 1.18
- RDY 0.20
- MACD
- AZTA 0.13
- RDY -0.07
- Stochastic Oscillator
- AZTA 70.88
- RDY 39.74
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.